Company Filing History:
Years Active: 2009
Title: **Sanjay Tukaram Gunjal: Innovator and Patent Holder**
Introduction
Sanjay Tukaram Gunjal is a notable inventor based in Mumbai, India. He has made significant contributions to the field of pharmaceuticals, particularly in the synthesis of vital compounds. His work exemplifies the innovative spirit that drives advancements in drug development.
Latest Patents
Sanjay holds a patent for a groundbreaking process titled "Process for manufacture of pure (2S, 3aS, 7aS)-1-[(2S)-2-[[(1S)-1-(ethoxycarbonyl) butyl]amino]-1-oxopropyl] octahydro-1H-indole-2-carboxylic acid and its tert. butyl amine salt." This invention presents new compounds that serve as synthetic intermediates essential for synthesizing perindopril, a crucial medication for treating high blood pressure. Additionally, his patent encompasses a new process for synthesizing perindopril as well as novel salts of the compound.
Career Highlights
Sanjay Gunjal is currently associated with Ipca Laboratories Limited, where he brings his innovative ideas to fruition. His dedication to research and development plays a significant role in enhancing the company's portfolio in the pharmaceutical sector.
Collaborations
Throughout his career, Sanjay has worked alongside talented colleagues, including Dilip Uttam Jadhav and Ashok Kumar. Their collaborative efforts contribute to the formulation of new pharmaceutical solutions and the advancement of existing methodologies in drug synthesis.
Conclusion
Sanjay Tukaram Gunjal is a distinguished inventor whose patent embodies a potential leap forward in the synthesis of essential pharmaceuticals. His contributions not only highlight his expertise but also underscore the importance of innovation in improving therapeutic options for patients worldwide.